Status:
COMPLETED
Bioequivalence of the Tablet and Liquid-Filled Capsule Forms of MK0974 (0974-042)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Migraine
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
This study will demonstrate the definitive bioequivalence of a solid dose formulation of MK0974 to the liquid filled capsule formulation of MK0974.
Eligibility Criteria
Inclusion
- Subject is in good health
- Subject is a nonsmoker
- Subject is willing to comply with the study restrictions
Exclusion
- Subject has history of stroke, chronic seizures, or any major neurological disorder
- Subject has a history of cancer
- Subject is a nursing mother
- Subject has uncontrolled high blood pressure
- Subject has or has a history of any disease or condition that might made participation in the study unsafe or confound the study results
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00966030
Start Date
March 1 2008
End Date
May 1 2008
Last Update
July 7 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.